To reduce this toll, we need to abandon analgesic drugs that act through the µ-opioid receptor and identify ... it recommended non-steroidal anti-inflammatory drugs (NSAIDs) for mild pain ...
Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.
Treatment with the drug was associated with a statistically ... which doesn’t tend to respond well to conventional analgesics. Earlier efforts to develop non-opioid painkillers for acute pain ...
In this study, pharmacogenomics and therapeutic drug monitoring were used to evaluate the clinical effectiveness of genotyping chronic pain patients on analgesic therapy. It was hypothesized that ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.